|
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection Clinical research trials and A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection. A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection clinical trial. Subjects frequently obtain the most expert healthcare possible for their A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection  A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
For Condition: HIV Infections,HIV Seronegativity
Status: Completed
Sponsor(s): Walter Reed Army Institute of Research (WRAIR) ,
Synopsis: The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.
Details: This study consists of 2 parts: Part A: Dose-escalation protocol using oligomeric gp160MN/LAI-2. Part B: Placebo-controlled, randomized, double-blind (within arm) study of vCP205 priming with gp160MN/LAI-2 boosting. Volunteers are followed for at least 1 year.
Eligibility:
Study Type: Interventional, Prevention, Double-Blind, Safety Study
Minimum Age/Maximum Age: 18 Years/55 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Volunteers may be eligible for this study if they: - Are HIV-negative. - Are in good health. - Are between ages 18 and 55. - Are available for at least 1 year. - Are a resident of the United States of America. - Agree to practice sexual abstinence or use birth control. Exclusion Criteria Volunteers will not be eligible for this study if they: - Have ever been given an HIV vaccine or certain other vaccines. (However, rabies vaccines are allowed.) - Participate in activities that place them at high-risk for HIV infection, such as injection drug use or unprotected sex with someone who has HIV infection. - Have certain psychiatric, medical, or substance abuse problems. - Are allergic to eggs or other vaccines. - Are an employee at a participating site and have access to study information. - Are taking certain medications. - Have received blood transfusions within 3 months before entering this study. - Are pregnant or breast-feeding.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
JeromeKim, Principal Investigator,
Walter Reed Army Institute of Research
Rockville, Maryland,
United States
Additional Information:
Study ID Numbers: RV124;
Study Start Date: April 1998
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004579
Other Hiv Seronegativity Studies:
1. Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
2. HIV-1 Vaccine Test in Uninfected Adult Volunteers
3. Long-Term Effects of HIV Exposure and Infection in Children
4. A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules
5. Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Related Studies:
Other HIV Seronegativity Clinical Trials
Other Maryland Clinical Trials
Other Rockville Clinical Trials
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
|
|
|
|
|
|
|
|
